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Stressful events have been implicated in the evolution of mood disorders. In addition
to brain neurotransmitters and growth factors, the view has been offered that these
disorders might be provoked by the activation of the inflammatory immune system as
well as by de novo changes of inflammatory cytokines within the brain. The present
review describes the impact of social stressors in animals and in humans on behavioral
changes reminiscent of depressive states as well as on cytokine functioning. Social
stressors increase pro-inflammatory cytokines in circulation as well as in brain regions
that have been associated with depression, varying with the animal’s social status
and/or behavioral methods used to contend with social challenges. Likewise, in humans,
social stressors that favor the development of depression are accompanied by elevated
circulating cytokine levels and conversely, conditions that limit the cytokine elevations
correlated with symptom attenuation or reversal. The implications of these findings are
discussed in relation to the potentially powerful effects of social support, social identity,
and connectedness in maintaining well-being and in diminishing symptoms of depression.
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Without dismissing the importance of other stressful experiences
in promoting mood disturbances, particular attention had been
devoted to the influence of social stressors in the emergence and
continuation of depressive disorders. Indeed, an array of social
stressors have been found to act in this capacity, including sep-
aration/divorce, unhealthy and unsupportive relationships, loss
of a friendship, social rejection, and social alienation (McQuaid
et al., 2014a; Slavich and Irwin, 2014). This focus has, in part,
stemmed from the frequent findings concerning the importance
of social identity and connectedness to psychological well-being
(Cruwys et al., 2013, 2014), as well as studies in rodents showing
that social challenges have profound and long-lasting effects on
neurobiological processes that have been implicated in depressive
disorders and adaptation (Chaudhury et al., 2013; Azzinnari et al.,
2014; Francis et al., 2014).
In addition to monoamine [e.g., serotonin (5-HT), nore-
pinephine (NE)], neuroendocrine [e.g., corticotropin-releasing
hormone (CRH)] and growth factor [e.g., brain-derived neu-
rotrophic factor (BDNF)] variations, it has been suggested that
depressive symptoms may stem from activation of the inflam-
matory immune system, especially that of pro-inflammatory
cytokines (e.g., signaling molecules normally released by immune
cells in the presence of infectious microorganisms). In this regard,
social stressors in rodents, especially those that involve trauma
in the form of aggressive social interactions, promoted several
neurobiological changes that have been implicated in depres-
sion. These have included elevated circulating corticosterone
levels (Audet and Anisman, 2010; Audet et al., 2011), increased
expression of CRH and its receptors (McQuaid et al., 2013), vari-
ations of monoamine turnover and levels (Audet and Anisman,
2010), and changes of neurotrophins such as BDNF (Berton et al.,
2006; Fanous et al., 2010) in brain areas that subserve stres-
sor appraisal processes as well as depression [prefrontal cortex
(PFC), hippocampus, amygdala, paraventricular nucleus (PVN)
of the hypothalamus, and nucleus accumbens]. In addition, social
stressors also affected pro-inflammatory cytokines both periph-
erally and within stress-sensitive brain regions (Bartolomucci
et al., 2003; Audet et al., 2010, 2011), supporting the view that
activation of these inflammatory markers may contribute to the
pathogenesis of stress-related disorders.
The effects elicited by social challenges may depend on the
animal’s social status or defensive strategies adopted during
aggressive interactions. For instance, active coping in the face of
aggressive encounters (e.g., active defense, hyperactivity, dom-
inance, aggression) limited or even prevented neuroendocrine
and neurochemical effects ordinarily elicited by the social stres-
sor, whereas strategies that involve less resistance (e.g., passive
defense, immobility, submissiveness) were related to more pro-
found stressor-induced variations (Bartolomucci, 2007; Audet
and Anisman, 2010; Audet et al., 2010; Gómez-Lázaro et al.,
2011). These outcomes may have been related to pre-existing
neurobiological features associated with genetic dispositions or
previous stressor experiences, which might have promoted vul-
nerability to adverse outcomes in response to social conflicts.
The present review delineates the pro-inflammatory impacts of
social stressors, with a focus on how these effects in vulnerable
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individuals may influence the emergence of later mood distur-
bances and mental health problems, and it is suggested that the
positive effects of social support and social connectedness on
mood states and well-being may be related to attenuation of pro-
inflammatory functioning. Figure 1 describes some of the factors
that may moderate the effects of social stressors on cytokine
functioning which then promote depressive states.
IMPLICATIONS OF THE INFLAMMATORY IMMUNE SYSTEM
IN DEPRESSIVE ILLNESSES
It has been about two decades since the suggestion was offered
that over-activation of the inflammatory immune system might
contribute to the pathogenesis of stress-related disorders, espe-
cially that of depressive illnesses (Maes, 1995). The inflammatory
hypothesis of depression postulated that elevated circulating lev-
els of pro-inflammatory cytokines might promote the evolution
and maintenance of depressive symptoms (Maes, 1995, 2008).
Meta-analyses have, in fact, indicated that in the absence of infec-
tious pathogens, peripheral concentrations of pro-inflammatory
cytokines, especially that of interleukin (IL)-6 and tumor necro-
sis factor (TNF)-α, were higher in non-medicated individuals
with depression than in non-depressed individuals (Dowlati et al.,
2010; Liu et al., 2012). Variations of IL-1β in relation to depres-
sive illnesses were less consistently established (Dowlati et al.,
2010; Liu et al., 2012), likely because of the difficulty in detect-
ing the very low levels of this cytokine in human circulation. In
addition to elevated pro-inflammatory levels, low serum levels
of the anti-inflammatory cytokine IL-10 were negatively corre-
lated to depressive symptoms in drug-free depressed individ-
uals (Dhabhar et al., 2009), suggesting that a shift toward a
pro-inflammatory state, comprising variations of either or both
pro- and anti-inflammatory functioning, may underlie depressive
symptoms.
Additional support for the inflammatory hypothesis of depres-
sion has come from reports showing that the prevalence of
depressive symptoms was relatively elevated in non-medicated
patients with chronic inflammatory diseases (e.g., chronic hep-
atitis C, multiple sclerosis) or acute inflammatory conditions
(e.g., surgery, stroke) (Musselman et al., 2001; Cremeans-Smith
et al., 2009). As well, immunotherapy with the pro-inflammatory
cytokine interferon (IFN)-α for chronic hepatitis C and some
types of cancers promoted depressive features (Capuron and
Miller, 2004). The latter findings not only support the view that
inflammatory factors could play a provocative role in depres-
sion, but it appeared that the depressive effects of IFN-α could
be attenuated by antidepressant treatments (Raison et al., 2006).
SOCIAL STRESSORS AND STERILE INFLAMMATORY
RESPONSES
The possible role for pro-inflammatory cytokines in depression
has been reinforced by the observation that stressful experi-
ences enhanced inflammatory activity in the absence of infec-
tious pathogens. In this regard, when experienced acutely, social
stressor challenges increased circulating concentrations of pro-
inflammatory cytokines, especially that of IL-6 and IL-1β (Steptoe
et al., 2007). Inflammatory activation has also been reported in
individuals chronically exposed to stressful life events, including
long-term care of a spouse with dementia (Kiecolt-Glaser et al.,
2003), bereavement (Schultze-Florey et al., 2012), prolonged
isolation (Yi et al., 2014), effort-reward imbalance at work
(Bellingrath et al., 2013), and low socioeconomic status (Gimeno
et al., 2007; Loucks et al., 2010). As these stressors may be associ-
ated with depression, these data are in keeping with the view that
chronic low-grade inflammation resulting from prolonged stres-
sor exposure may be fundamental in the onset of stress-related
depressive symptoms.
Among the different stressors that can be experienced, one of
the most significant for the emergence of neuropsychiatric symp-
toms are those involving a violent or traumatic component (e.g.,
in the form of neglect, maltreatment/abuse, aggression). Based
on a meta-analysis, it was concluded that trauma exposure dur-
ing either childhood or adulthood was positively associated with
levels of IL-1β, IL-6, and TNF-α, (but not of IL-2, IL-4, IL-
8, or IL-10) and these associations were especially pronounced
in individuals who had developed neuropsychiatric symptoms,
irrespective of their nature (Tursich et al., 2014). Associations
between early-life adversities and higher levels of inflammatory
factors have been reported among adults (Danese et al., 2007;
Hartwell et al., 2013) but also among children and adolescents
(Slopen et al., 2013). Thus, the view was taken that increased
inflammatory activity associated with trauma exposure could
be initiated shortly after trauma and persist over an extended
period of time (or be re-induced, and even exacerbated, upon
re-experiencing stressors), possibly progressively fostering sensi-
tivity to later health or mood disturbances. In fact, in addition
to having higher baseline cytokine levels, individuals at risk for
the development of neuropsychiatric symptoms (owing to previ-
ous traumatic experiences) appeared to be more sensitive to the
cytokine effects normally induced by a socially stressful experi-
ence or to the low-grade inflammation associated with chronic
stressors. Higher cytokine levels in individuals with a history
of childhood adversities were more pronounced in those cur-
rently experiencing high levels of distress, either acutely or on
a chronic basis (Carpenter et al., 2010; Kiecolt-Glaser et al.,
2011). Thus, the heightened vulnerability to psychiatric condi-
tions in individuals who had been confronted with traumatic
events might be related, at least in part, to a fragility or hyper-
responsiveness of inflammatory processes resulting from earlier
negative experiences (Anisman et al., 2008).
PERIPHERAL vs. CENTRAL CYTOKINE PROCESSES IN
DEPRESSION
The significance of peripheral inflammatory activation in rela-
tion to depression is uncertain, especially as mood improvements
elicited by medication are not consistently accompanied by a
normalization of cytokine levels (Eller et al., 2009; Hannestad
et al., 2011). Whereas circulating cytokines may directly or indi-
rectly contribute to the evolution of depressive symptoms, their
increased presence in circulation may also be a reflection of
the distress experienced by depressed individuals (particularly
as depression would itself act as a stressor). Ultimately, how-
ever, depression is probably more closely aligned with cytokine
variations that occur in the brain or with effects secondary to
such changes, including variations of brain neurotransmitters,
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FIGURE 1 | A schematic representation of the relations between social
stressors, pro-inflammatory cytokines, and depressive states, with a
particular focus on the individual and environmental factors that may
moderate these effects. It is suggested that in addition to sex and age,
the capacity of social stressors to promote inflammatory variations that
might lead to depression may be influenced by the presence of genetic
and personality factors. For instance, individuals carrying specific gene
combinations or polymorphisms (e.g., variants of IL-6, IL-1β, TNF-α) may be
more vulnerable to the depressive effects of inflammatory activation
provided that they also encounter social stressors. In addition, it is
proposed that environmental factors may also impact on stress-related
cytokine responses and thus on depressive symptoms. For example,
previous stressor experiences in the form of prenatal or early-life adversity
or immunological challenges as well as gut bacterial disturbances may
influence inflammatory processes and sensitize immune responses to
subsequent stressors, thus favoring the emergence of depressive
symptoms. However, in the context of adequate coping strategies, higher
social status, or in the presence of effective social support, the cytokine
effects of stressors may be limited thus buffering against mood
disturbances. The activation of pro-inflammatory processes may directly or
indirectly influence depressive states. Elevations of cytokines may influence
monoamine (e.g., 5-HT, NE), hormone (e.g., CRH), and growth factor (e.g.,
BDNF) activity which might favor the evolution of depression (and basal
hormonal and neurochemical functioning may impact cytokine processes).
Alternatively, cytokine variations may stimulate the enzyme indoleamine
2,3-dioxygenase (IDO) and promote the release of neurotoxic metabolites,
including kynurenic acid, quinolinic acid, or 3-hydroxykynurenine, and cause
oxidative stress, culminating in depression.
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hormones, or growth factors (see Audet and Anisman, 2013).
Several reports also point to the possibility that processes in other
organs that share reciprocal connections with the brain, including
the microbiota present in the gastrointestinal tract, may also play
an important role in this regard (Cryan and Dinan, 2012; Haroon
et al., 2012).
A small portion of the pro-inflammatory cytokines released
into circulation may access the brain at circumventricular sites
(Vitkovic et al., 2000) or through saturable transport systems
(Banks, 2006). Thus, cytokine elevations that occur peripherally
among stressed and/or depressed individuals might be reflected in
the central nervous system, especially as several of the cytokines
altered in circulation were also dysregulated in the brain of indi-
viduals with depression or with conditions that had been related
to and/or are comorbid with the disorder. It is particularly sig-
nificant, however, that pro-inflammatory cytokines may also be
produced endogenously by brain microglia in response to inflam-
matory or stressor stimuli (Quan et al., 1998; Dantzer et al., 2008;
Sukoff Rizzo et al., 2012; Schwartz et al., 2013). The few studies
that examined brain cytokine variations in relation to depression
revealed that several pro- and anti-inflammatory cytokines (e.g.,
IL-1α, IL-2, IL-3, IL-5, IL-8, IL-9, IL-10, IL-12A, IL-13, IL-15, IL-
18, IFN-γ, and TNF) were up-regulated in post-mortem frontal
cortex of depressed patients who had died by natural causes or
through suicide (Dean et al., 2010; Shelton et al., 2011). In con-
trast, in the PVN of the hypothalamus, changes in TNF-α or IL-1β
mRNA expression were not observed in depressed patients rela-
tive to healthy controls (Wang et al., 2008). A potential role for
brain cytokine elevations in depression has also been confirmed
in studies using rodent models of the disorder. Social conflicts
in male mice increased plasma IL-6 and IL-1β levels and altered
mRNA expression of the same cytokines in the PFC and hip-
pocampus (Bartolomucci et al., 2003; Audet et al., 2010, 2011).
Moreover, genetic deletion of the IL-1 receptor type 1 on endothe-
lial cells limited brain elevations of IL-1β, TNF-α, and IL-6mRNA
expression elicited by repeated social defeat, indicating that IL-1
signaling likely plays a role in social stress-induced activation of
pro-inflammatory cytokines (Wohleb et al., 2014). This is not to
say that social stressors are uniquely capable of provoking such
changes, as strong physical stressors known to elicit depressive-
like behaviors, such as those involving shock and immobilization,
increased IL-1β protein and mRNA in serum and in the hypotha-
lamus (O’Connor et al., 2003; Deak et al., 2005) as well as IL-6 in
the frontal cortex (Sukoff Rizzo et al., 2012). Likewise, a chronic
unpredictable mild stressor regimen that promoted depressive-
like features also increased TNF-α levels in the PFC (Liu et al.,
2013).
NEW PLAYERS IN THE CYTOKINE HYPOTHESIS OF
DEPRESSION
Beyond variations of the traditional pro-inflammatory cytokines
IL-6, IL-1β, and TNF-α, depression has been associated with ele-
vations of circulating IL-18, which is involved in cell-mediated
immunity (Merendino et al., 2002; Prossin et al., 2011), and
macrophage migration inhibitory factor (MIF), which is con-
sidered to be a pro-inflammatory cytokine that has neurogenic
actions (Musil et al., 2011; Cattaneo et al., 2013). Consistent
with these peripheral changes, IL-18 expression in the neocor-
tex increased in subordinate rats after an agonistic encounter
(Kroes et al., 2006). As well, genetic deletion of MIF blocked the
increased cell proliferation normally elicited by the antidepressant
fluoxetine (Conboy et al., 2011), and limited the antidepres-
sant effects and the increased hippocampal BDNF expression
ordinarily elicited by exercise (Moon et al., 2012). In addition
to pro-inflammatory cytokines, several growth factors including
BDNF as well as basic fibroblast growth factor (FGF-2), nerve
growth factor (NGF), vascular endothelial growth factor (VEGF),
and erythropoietin (EPO) have been implicated in depressive dis-
orders (see Audet and Anisman, 2013 for a detailed description).
These growth factors are also influenced by stressors (Cirulli and
Alleva, 2009) and as indicated previously (Audet and Anisman,
2013), they may interact with cytokines in affecting behavioral
phenotypes.
SOCIAL STRESSORS, CYTOKINES, AND DEPRESSION: DOES
SEX MATTER?
The clinical observation that vulnerability to mood disturbances
is more pronounced in women than in men has raised the pos-
sibility that males and females might also differ with respect to
biological variations that could be linked to depressive symp-
toms. However, it was reported that females might be more
resilient to the cytokine variations associated to depressive states
or to stressor exposure. For instance, IL-6 elevations elicited
by an acute stressor occurred earlier in men than in women
(Edwards et al., 2006). Moreover, elevated levels of IL-6 were
apparent in depressed men, but not in depressed women with
a late onset of symptoms (Vogelzangs et al., 2012) or suffering
from social isolation (Häfner et al., 2011). Animal studies also
showed that increased depressive-like behaviors were observed in
female but not male IL-10 knockout mice (Mesquita et al., 2008).
As well, sensitized IL-1β expression in the PFC and hippocam-
pus apparent after a second stressor exposure in stressed males
was not apparent in females (Hudson et al., 2014). Consistent
with a role for sex hormones in such outcomes, in females foot-
shocks increased IL-1 expression in the PVN during the diestrus,
proestrus, and estrus stages, whereas no elevations were observed
during the metestrus stage, suggesting that endogenous proges-
terone may play a role in the PVN IL-1 response to stressors
(Arakawa et al., 2014). This complex picture implies that addi-
tional players may contribute to the mood disturbances apparent
in females and the question that has to be asked is whether sex
hormones (e.g., estrogen, progesterone) play a more provocative
role in inflammatory processes than what was initially thought.
CYTOKINE VARIATIONS, AGGRESSIVENESS, AND
IMPULSIVITY
It is interesting that the inflammatory variations observed among
victims of traumatic events are also apparent in individuals per-
petrating aggressive or violent acts, and it was suggested that
activity of specific cytokines might modulate aggressive and
impulsive behaviors. For instance, being physically aggressive
during childhood and adolescence predicted reduced baseline lev-
els of pro- (IL-6, IL-1α) and anti-(IL-4, IL-10) inflammatory
cytokines in early adulthood (Provençal et al., 2013). Likewise,
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in mice, peripheral administration of IL-1β suppressed aggres-
sive actions during agonistic encounters (Cirulli et al., 1998).
Moreover, among mice that did not express IL-6 the frequency
of aggressive postures was elevated and affiliative behaviors were
low, whereas overexpression of IL-6 was accompanied by elevated
affiliative behaviors (Alleva et al., 1998). Curiously, however,
higher plasma IL-6 concentrations in individuals with intermit-
tent explosive disorder were directly correlated with their history
of actual aggressive behaviors (Coccaro et al., 2014). Likewise,
gene expression of TNF-related cytokines was related to aggres-
sion scores in adolescents with bipolar disorder (Barzman et al.,
2014). Additional support for a role for inflammatory markers in
impulsive or violent behaviors have come from reports showing
enhanced levels of pro-inflammatory cytokines among individ-
uals showing deliberate self-harm (Westling et al., 2011), high
rage scores (Pesce et al., 2013), or pronounced hostile behaviors
(Marsland et al., 2008). Why reduced vs. enhanced cytokine levels
were apparent among individuals with aggressive and/or impul-
sive features in these studies is not entirely clear. Higher levels of
childhood maltreatment have been reported in adults with inter-
mittent explosive disorder compared with psychiatric and healthy
controls (Fanning et al., 2014). Considering that early-life trauma
has been linked to a subsequent increase of inflammatory activity,
it might be suggested that the roots and trajectory of aggression
(being physically abused vs. being physically aggressive as a child)
might have played a role in the different inflammatory patterns
observed in these studies.
Consistent with the suggestion that violent and/or impul-
sive behaviors may be linked to neuropsychiatric conditions,
increased IL-1β, IL-6, and TNF-α in post-mortem PFC were
observed in teenaged individuals that died by suicide, irrespec-
tive of whether they had been diagnosed with major depres-
sion (Pandey et al., 2012). Increased protein levels of Toll-like
receptors 3 and 4 (associated with increased production of pro-
inflammatory cytokines) were also found in post-mortem PFC of
depressed adults that had died by suicide compared to that evi-
dent in depressed individuals that had died from a cause other
than suicide (Pandey et al., 2014). The fact that increased inflam-
matory activation had been observed in post-mortem brains of
suicide individuals is of particular importance, as it raises the
possibility that central cytokine variations are linked to suicide
rather than depression per se. Although suicidal thoughts or
ideations may be a symptom of major depression, actual suicide
attempts are not necessarily reflective of depressive illnesses, but
might be indicative of additional factors, such as impulsivity and
extreme or violent behaviors. In this regard, elevated IL-6 lev-
els found in the cerebrospinal fluid of suicidal individuals were
more pronounced in those that made efforts of violent suicide
(Lindqvist et al., 2009).
SOCIAL TRAUMA: SOCIAL STATUS AND DEFENSE
STRATEGIES MATTER
It has long been known that social hierarchy, depending on
whether the organism is at the top or bottom of the hierar-
chy, can be particularly stressful and can have marked effects
on health and well-being (Sapolsky, 2005). Indeed, the stabil-
ity of the hierarchy and the availability of resources can have
considerable sway on the adaptive neurobiological processes that
occur in dominant and submissive/subordinate animals, as can
affiliative behaviors of a group, gender, and individual difference
factors (personality). Considering that individuals with aggres-
sive profiles may also be vulnerable to neuropsychiatric disorders,
the investigation of the potential victim/aggressor dichotomy in
relation to inflammatory variations prompted further investiga-
tion. Preclinical studies indicated that although aggressive social
interactions promoted comparable corticosterone elevations in
submissive and dominant mice, some of the cytokine variations
elicited were influenced by social status (Audet et al., 2010).
Specifically, circulating IL-6 elevations after social conflicts were
more pronounced in submissive mice (Audet et al., 2010). As
well, higher spleen levels of TNF-α and IL-6 were apparent among
mice using passive behaviors (e.g., immobility, decreased reactiv-
ity, and low aggression) during aggressive encounters compared
to those using active defense strategies (e.g., aggression and terri-
torial control) or to non-stressed controls (Gómez-Lázaro et al.,
2011). In contrast, in dominant/winner mice, higher levels of the
anti-inflammatory cytokine IL-10 (Stewart et al., 2014) and IL-
6 up-regulations were apparent in the PFC (Audet et al., 2010).
Together, these findings suggest that active coping strategies dur-
ing aggressive interactions may be more effective in moderating
the cytokine impacts of stressors involving social conflicts than
strategies that involve less resistance (Gómez-Lázaro et al., 2011).
How these cytokine variations come to be translated into specific
behavioral changes is uncertain, nor is it known how chronicity of
social stressors will affect cytokine-related disturbances, although
it seems that chronic social stressors favor the development of
varied pathological conditions (Sapolsky, 2005).
Similar distinctions based on the behavioral strategies used
during aggressive encounters in rodents have been reported
with respect to other neurochemical markers. In this regard,
the increased NE utilization within the PFC and hippocampus
observed after social conflicts was more pronounced in submis-
sive than in dominant mice (Audet and Anisman, 2010). As well,
latency to escape from an aggressor during a social defeat episode
was negatively correlated with BDNF mRNA expression in the
hippocampus, suggesting that an active response strategy during
stressor exposure might be associated with higher hippocampal
BDNF (Arendt et al., 2012). Likewise, depressive-like behaviors
and hippocampal BDNF protein reductions were only apparent
in those defeated mice that displayed a passive profile during
agonistic interactions (Gómez-Lázaro et al., 2011).
THE CYTOKINE HYPOTHESIS OF DEPRESSION FACING NEW
CHALLENGES
There are several unresolved issues pertaining to the relation-
ships between social stressors, pro-inflammatory activation, and
depression. Beyond individual differences related to sex, social
status, or defense strategies described earlier, whether inflamma-
tory variations and depressive features will emerge as a result of
stressor exposure may not always occur and the multiple pro-
cesses by which this comes about remain to be fully established.
For instance, it is uncertain whether a single cytokine is of par-
ticular relevance in regard to the provocation of depression, or
whether symptoms (or clusters of symptoms) evolve owing to
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multiple cytokine actions or to interactions between cytokines
and other factors. Most studies that examined the relations
between circulating cytokines and depression have considered the
illness from a broad perspective rather than one that focused on
specific symptoms or on depression subtypes. However, it seems
that HPA axis and sympathetic nervous system activity (Gold and
Chrousos, 2002), as well as that of circulating IL-1β and IL-6
(Anisman et al., 1999; Dunjic-Kostic et al., 2013), may vary greatly
in individuals with typical vs. atypical features of major depres-
sion. In line with this view, a positive correlation between severity
of depressive symptoms and IL-6 concentrations was found in
melancholic patients, whereas a negative correlation was appar-
ent in depressed patients with atypical features (Karlovic´ et al.,
2012). Whether links exist between other cytokines and specific
characteristics of the illness remains to be determined, but specific
attention needs to be paid to whether inflammatory activation is
linked to specific depressive symptoms and not to others.
The fact that traditional antidepressant medication may
limit depressive symptoms without affecting pro-inflammatory
cytokine activity (Anisman et al., 1999; Eller et al., 2009;
Hannestad et al., 2011) and that anti-inflammatory treatments
are not systematically effective in limiting depressive symptoms
(Köhler et al., 2014), also begs the question as to what the specific
contribution of circulating pro-inflammatory cytokines might be
in mediating depressive symptoms. Are these cytokines merely
peripheral markers of depression or are they involved in the
provocation of illness? Are these cytokines reflective of an ongo-
ing biological dysfunction that would inform treatment resistance
or vulnerability to relapse? If depression (or most likely specific
depressive subtypes) is driven by inflammation, then traditional
antidepressants would be expected to improve mood through
cytokine-dependent mechanisms, and anti-inflammatory treat-
ments would be effective in attenuating symptoms. However, this
would only occur in those patients in whom depressive symp-
toms were precipitated by inflammatory factors. In this regard,
there has been growing acknowledgment of the limited suc-
cess in defining the genetic and biological complements that are
associated with depression, and the suggestion was made that
individualized treatment for the illness, based on biologically rele-
vant markers, may be instrumental in guiding treatment selection
and enhancing outcomes. Indeed, the identification of specific
cytokine markers that might be aligned with particular symp-
toms or subtypes of depression could be especially useful in the
prediction of treatment efficacy.
NEW AVENUES FOR THE INFLAMMATORY HYPOTHESIS OF
DEPRESSION
As already intimated, the processes by which cytokine elevations
are elicited by social stressors, and how these come to affect brain
functioning, are still not known. In addition to cytokine varia-
tions that occur in the brain, neurobiological alterations elicited
by stressors at various peripheral sites that interact with brain
processes may be relevant to stressor-related disorders, includ-
ing depression. In this regard, increasing interest has focused on
the inflammatory variations that might occur along the gut-brain
axis (Cryan and Dinan, 2012; Haroon et al., 2012). It has been
suggested that microorganisms that inhabit the gastrointestinal
tract, referred to as the gut microbiota, might play an impor-
tant role in inflammatory responses elicited by stressors. The gut
is inhabited by 1013–1014 commensal bacteria that interact with
each other and modulate other systems, including the immune
functioning. Alterations in the composition and diversity of the
gut microbiota by environmental insults, including stressors, have
been correlated with plasma cytokine elevations (Bailey et al.,
2011). Moreover, reduction of the gut microbiota by antibiotics
prevented the stressor-induced cytokine elevations, indicating
that bacteria that live in the gut were necessary for an inflamma-
tory stress response to develop (Bailey et al., 2011). Given that
microbiota may have immunoregulatory effects through actions
on immune cells, it was suggested that probiotic bacteria (i.e.,
“good” bacteria that when ingested confer a benefit for the host),
by their interactions with commensal gut bacteria, may also influ-
ence inflammatory responses elicited by stressors. In support of
this view, plasma elevations of pro-inflammatory cytokines pro-
voked by a psychological stressor were prevented in rats treated
with the probiotic Bifidobacterium infantis (Desbonnet et al.,
2010).
Accumulating data have also indicated that the gut microbiota
may interact with the central nervous system and that alterations
of microbiota composition could modulate brain functions and
behaviors (Cryan and Dinan, 2012; Dinan and Cryan, 2012). For
example, reduced anxiety-like behaviors as well as altered expres-
sion of BDNF and of a variety of NMDA and 5-HT receptors were
reported in germ-free mice (i.e., mice that had been maintained
in a sterile environment and never been exposed to bacterial
microbe) and in mice treated with antibiotics that disrupted gut
bacteria (Sudo et al., 2004; Bercik et al., 2011a; Neufeld et al.,
2011). Moreover, administration of particular probiotic strains
attenuated anxiety and depressive behaviors in rodents (Bravo
et al., 2011) and in healthy humans (Messaoudi et al., 2011). As
well, ingestion of probiotics in rodents affected central expression
of GABA receptor subunits (Bravo et al., 2011), BDNF (Bercik
et al., 2011b), and twomarkers of microglial activation, CD68 and
CD11b (Distrutti et al., 2014), although themechanisms by which
this occurred have not been identified.
INFLAMMATORY GENE VARIANTS AS RISK FACTORS FOR
DEPRESSION AND AS PREDICTORS OF TREATMENT
RESPONSE
It has been suggested that inflammatory cytokine activity might
serve as a biomarker to predict how individuals cope with stres-
sors, whether they develop depression, and/or whether they
respond to different treatment strategies (Anisman et al., 2008;
Yoshimura et al., 2009; Cattaneo et al., 2013). Beyond protein
or gene expression variations, allelic variants of genes [e.g., in
the form of gene polymorphisms, including single-nucleotide
polymorphisms (SNPs)] that promote higher transcription of
pro-inflammatory cytokines appear to be related to inflamma-
tory variations normally elicited by stressors and in some cases
to predict the emergence of depressive symptoms (Bufalino et al.,
2013). For instance, cytokine elevations in bereaved individ-
uals were apparent in homozygous carriers of the mutant G
allele of the IL-6-174C polymorphism (associated with high IL-6
transcription), but not in those carrying the low transcription
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C allele (Schultze-Florey et al., 2012). Considering that a posi-
tive association between depression and mortality risk has been
found in homozygous carriers of the high transcription G allele of
the IL-6-174C polymorphism (Cole et al., 2010), it was suggested
that the low transcription C allele may protect against physical
andmental health problems associated with psychological distress
(Schultze-Florey et al., 2012). In support of these findings, depres-
sive symptoms elicited by IFN-α immunotherapy in patients with
chronic hepatitis C were reduced in those carrying the C allele of
the IL-6-174C polymorphism (Bull et al., 2009). In addition to
IL-6, variants of the genes encoding for IL-1β and TNF-α have
also been associated with elevated risk for depression (Bufalino
et al., 2013). Parenthetically, paralleling the effects of stressors,
the depressive effects of immunotherapy were less pronounced
among individuals carrying the two long (L/L) alleles of the sero-
tonin transporter gene-linked polymorphic region (5-HTTLPR)
relative to individuals carrying the short (S) allele, pointing to the
possibility that IFN-α immunotherapy operates like stressors in
predicting the development of depression (Bull et al., 2009). Thus,
in addition to cytokine sensitivity elicited by external factors
(e.g., traumatic events), polymorphic variations on inflammatory
genes might also contribute to the vulnerability to social stressors
and to the development of depressive illnesses. Whether environ-
mental and genetic influences interact in this regard remains to
be investigated, but given the influence of stressors on cytokine
functioning, such interactions would be expected.
Just as increased levels of IL-6 (Lanquillon et al., 2000;
Yoshimura et al., 2009) as well as up-regulated expression of
IL-1β and TNF-α (Cattaneo et al., 2013) predicted a lack of
response to different classes of antidepressants, polymorphisms
of the IL-1β, IL-6, and IL-11 genes, which were associated
with increased cytokine production, were accompanied by a
diminished response to antidepressant medication (Uher et al.,
2010; Bufalino et al., 2013). Based on these findings, it had
been suggested that depressed individuals who repeatedly fail
to respond to traditional antidepressants may exhibit a distinct
pro-inflammatory profile. This possibility was confirmed in ani-
mal studies showing that mice engineered to overexpress IL-6
in the frontal cortex and hippocampus as well as mice that
had received intracerebroventricular injections of IL-6 showed
a blunted response to the antidepressant effects of fluoxetine
(Sukoff Rizzo et al., 2012). In essence, elevated levels of partic-
ular cytokines may predict the development of depression, and
although IL-6 and TNF-α levels may decline with appropriate
treatment (Lanquillon et al., 2000; Yoshimura et al., 2009), if
the cytokine levels are too high prior to treatment commencing,
possibly reflecting a disturbance of regulatory/inflammatory pro-
cesses, the effects of antidepressant treatments will be muted. It is
equally possible that the elevated cytokine levels that sometimes
persist despite positive mood changes elicited by antidepressant
treatment may reflect a harbinger for illness recurrence (see
Anisman et al., 2008).
CYTOKINE VARIATIONS AND POSITIVE
ENVIRONMENTS—THE GOOD AND THE BAD
If negative events promote cytokine disturbances that undermine
well-being, is it the case that positively interpreted events and
experiences act against cytokine disturbances and the emergence
of depression? Studies in animals have indicated that positive
interventions in animal models of depression are associated with
reductions of stress-induced cytokine elevations. For instance,
increased TNF-α and IL-6 mitogen-stimulated splenocyte pro-
duction induced by separation from a mom or littermates was
attenuated in young piglets that were paired with an aged-
matched conspecific (Tuchscherer et al., 2014). As well, in mice,
long-term exposure to an enriched environment reduced IL-1β
and TNF-α elevations in the hippocampus induced by influenza
infection (Jurgens and Johnson, 2012). That said, it has also been
shown that environmental enrichment inmalemice enhanced the
cytokine effects normally elicited by social defeat, probably owing
to the aggressive behaviors promoted by enrichment in male mice
(McQuaid et al., 2013).
The data derived from human studies have similarly revealed
that positive experiences may act against cytokine variations,
which could influence mood states. For instance, psychoso-
cial measures of coping and self-esteem were inversely corre-
lated to IL-6 levels (Sjögren et al., 2006) and improvements in
coping strategies and resilience after self-administered hypno-
sis were associated with IL-6 reductions (Schoen and Nowack,
2013). A meta-analysis also demonstrated that mind-body ther-
apies (e.g., Tai Chi, meditation, yoga) tended to reduce IL-6
levels in both healthy and clinical populations (Morgan et al.,
2014). Importantly, reductions of depressive symptoms after
daily yogic meditation intervention (Black et al., 2013), a mind-
fulness treatment program (Carlson et al., 2007; Rosenkranz
et al., 2013), and cognitive-behavioral therapy (Gazal et al.,
2013) were all related to pro-inflammatory cytokine reduc-
tions.
Social factors, and particularly having social support, have
long been known to diminish some of the adverse effects of stres-
sors. By example, the availability of social support was accom-
panied by reduced levels of cortisol both in a natural setting
and within a laboratory context (Heinrichs et al., 2003). Further,
in a stress test the right PFC activation and diminished amyg-
dala activity that were ordinarily elicited could be attenuated by
having social support available (Taylor et al., 2008), and hav-
ing received social support over several days blunted the cortisol
response ordinarily elicited by a social stressor and enhanced neu-
ronal activity within the anterior cingulate cortex (Eisenberger
et al., 2007). There have similarly been reports showing that social
support could influence the plasma cytokine response otherwise
elicited by stressors, and could thus influence mood state (Slavich
and Irwin, 2014). In fact, it has broadly been reported that among
cancer survivors who had social support prior to treatment, later
well-being was enhanced. In fact, in the individuals with lower
pretreatment social support, the levels of IL-6 increased with
illness progression, which predicted the elevation of depressive
symptoms (Hughes et al., 2014).
A similar link between social support, cytokines, and gen-
eral well-being has also been observed among medically healthy
individuals. Specifically, low social status was accompanied by ele-
vated IL-6 in response to a stressor (Derry et al., 2013), and social
strain emanating from family and friends increased circulating
IL-6, whereas having social support modestly protected against
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this outcome (Yang et al., 2014). Moreover, the rise of IL-6 associ-
ated with anger was not evident among individuals who perceived
themselves as having high social support (Puterman et al., 2013).
The data available concerning the influence of social stressors
and social support on cytokine levels is still limited. Nonetheless,
it is certain that social stressors, especially those of an interper-
sonal nature, such as social rejection and social adversity, can be
particularly aversive and it has been suggested that the depres-
sive actions of such experiences may involve activation of pro-
inflammatory processes (Slavich and Irwin, 2014). However, it
might not always be the case that social support will be prophylac-
tic or remedial in attenuating the effects of stressful experiences,
especially if efforts of support are interpreted as being insufficient
or actually a reflection of an unsupportive interaction (McQuaid
et al., 2014b).
CONCLUDING COMMENTS REGARDING CYTOKINE
INVOLVEMENT IN DEPRESSION AND ITS COMORBIDITIES
The specificity of cytokine disturbances to depression has fre-
quently been questioned. In this regard, it was demonstrated
that despite the overlap that exists with respect to the symptoms
of IFN-α-induced and idiopathic depression, there are differ-
ences between the two, leading to the suggestion that cytokines
preferentially affect neural circuits associated with psychomotor
activity, but have less of an effect on the processes that govern cog-
nitive distortions concerning self-appraisal (Capuron et al., 2009).
Furthermore, increased inflammatory activity has been reported
in a variety of stress-related disorders, including bipolar disorder
(Modabbernia et al., 2013), schizophrenia (Altamura et al., 1999),
and post-traumatic stress disorder (Lindqvist et al., 2014), and
has been associated with a number of chronic diseases includ-
ing cancers, heart diseases, metabolic syndrome, diabetes and
obesity, auto-immune illnesses, disorders of the digestive system
(i.e., inflammatory bowel disease), and neurodegenerative disor-
ders (Anisman et al., 2008). In essence, it is possible that altered
cytokine functioning might create a general milieu that favors
the development of pathology, but the specific disturbance that
is expressed depends on the presence of still other factors being
affected. This said, as most of these conditions are often comorbid
with depression, it has been suggested that increased inflamma-
tion might be a common denominator underlying depressive
symptoms across many neuropsychiatric and physical/medical
conditions. Indeed, the link between depression and the devel-
opment of illnesses, such as heart disease, is sufficiently strong
to have prompted the suggestion that the presence of depres-
sion ought to be viewed as a marker for later physical illnesses
(Hayley and Anisman, 2013). Just as stressful events, particularly
those that involve social challenges, promote cytokine varia-
tions and several pathological conditions, social support has been
effective in attenuating these outcomes. Considerable evidence
indicates that the effectiveness of support depends on whom
the support comes from, and the individual’s social identity and
social connectedness may be involved in the resolution of depres-
sion (Cruwys et al., 2013, 2014). It remains to be determined
whether the positive effects of social identity and connected-
ness in attenuating depression operate through inflammatory
processes.
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